Literature DB >> 6339448

Identification of a hypoxic population of bone marrow cells.

M J Allalunis, J D Chapman, A R Turner.   

Abstract

A technique using collagenase has been devised to release and separate, with reproducibility, hematopoietic cells (HC) from various microenvironments of mouse femurs. HC were assayed by an in vitro gel culture technique used traditionally to score granulocyte-macrophage precursor cells (CFU-C). CFU-C which resided in the medullary cavity and endosteal regions were sensitive to ionizing radiation and resistant to misonidazole (MISO) cytotoxicity. CFU-C which resided within the compact bone were resistant to ionizing radiation and sensitive to the cytotoxic action of MISO. These results suggest that HC which reside in the bone are hypoxic and retain clonogenic potential. When animals were exposed to various treatments with MISO followed by myelotoxic doses of cyclophosphamide (CTX) or total body irradiation (TBI), the LD50 of both agents was significantly reduced. This result suggests that a hypoxic component of HC could be important in the regenerative process within the marrow after such myelotoxic trauma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339448     DOI: 10.1016/0360-3016(83)90104-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Enhanced growth of myelodysplastic colonies in hypoxic conditions.

Authors:  James Edwin Thompson; Joseph Patrick Conlon; Xiaowei Yang; Patricia Vanessa Sanchez; Martin Carroll
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

2.  The in situ tumour response to combinations of cyclophosphamide and tirapazamine.

Authors:  D W Siemann
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.

Authors:  J M Cline; D E Thrall; R L Page; A J Franko; J A Raleigh
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

Review 4.  One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.

Authors:  Elisabetta Rovida; Ilaria Marzi; Maria Grazia Cipolleschi; Persio Dello Sbarba
Journal:  Hypoxia (Auckl)       Date:  2014-01-21

5.  Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs.

Authors:  Dinghua Liang; Xing Wu; Brian B Hasinoff; David E Herbert; Geoffrey K Tranmer
Journal:  Molecules       Date:  2018-08-15       Impact factor: 4.411

6.  Oxygen and Cell Fate Decisions.

Authors:  Qun Lin; Yuri Kim; Rodolfo M Alarcon; Zhong Yun
Journal:  Gene Regul Syst Bio       Date:  2008-02-10

7.  Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.

Authors:  P J O'Dwyer; F P LaCreta; J Walczak; T Cox; S Litwin; J P Hoffman; M Zimny; R L Comis
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

8.  The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction.

Authors:  Giulia Cheloni; Martina Poteti; Silvia Bono; Erico Masala; Nathalie M Mazure; Elisabetta Rovida; Matteo Lulli; Persio Dello Sbarba
Journal:  Stem Cells Int       Date:  2017-06-04       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.